J
Jens-Ulrik Stæhr Jensen
Researcher at University of Copenhagen
Publications - 162
Citations - 3740
Jens-Ulrik Stæhr Jensen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 100 publications receiving 2545 citations. Previous affiliations of Jens-Ulrik Stæhr Jensen include Health Science University & University of Copenhagen Faculty of Health Sciences.
Papers
More filters
Journal ArticleDOI
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz,Yannick Wirz,Ramon Sager,Mirjam Christ-Crain,Daiana Stolz,Michael Tamm,Lila Bouadma,Charles Edouard Luyt,Michel Wolff,Jean Chastre,Florence Tubach,Kristina B. Kristoffersen,Olaf Burkhardt,Tobias Welte,Stefan Schroeder,Vandack Nobre,Long Wei,Heiner C. Bucher,Neera Bhatnagar,Djillali Annane,Konrad Reinhart,Angela Branche,Pierre Damas,Maarten W. N. Nijsten,Dylan W. de Lange,Rodrigo Octavio Deliberato,Stella Ss Lima,Vera Maravic-Stojkovic,Alessia Verduri,Bin Cao,Yahya Shehabi,Albertus Beishuizen,Jens-Ulrik Stæhr Jensen,Caspar Corti,Jos A H van Oers,Ann R. Falsey,Evelien de Jong,Carolina F. Oliveira,Bianca Beghe,Matthias Briel,Beat Mueller +40 more
TL;DR: In this article, a systematic review included individual patient data from 14 randomised controlled trials with a total of 4211 participants and found no increased risk for all-cause mortality or treatment failure when procalcitonin was used to guide initiation and duration of antibiotic treatment in participants with acute respiratory infections compared to control participants.
Journal ArticleDOI
Procalcitonin increase in early identification of critically ill patients at high risk of mortality.
Jens-Ulrik Stæhr Jensen,Lars Heslet,Tom Hartvig Jensen,Kurt Espersen,Peter Steffensen,Michael Tvede +5 more
TL;DR: A high maximum procalcitonin level and a procalCitonin increase for 1 day are early independent predictors of all-cause mortality in a 90-day follow-up period after intensive care unit admission.
Journal ArticleDOI
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
Philipp Schuetz,Yannick Wirz,Ramon Sager,Mirjam Christ-Crain,Mirjam Christ-Crain,Daiana Stolz,Daiana Stolz,Michael Tamm,Michael Tamm,Lila Bouadma,Charles Edouard Luyt,Michel Wolff,Jean Chastre,Florence Tubach,Kristina B. Kristoffersen,Olaf Burkhardt,Tobias Welte,Stefan Schroeder,Vandack Nobre,Long Wei,Heiner C. Bucher,Heiner C. Bucher,Djillali Annane,Konrad Reinhart,Ann R. Falsey,Angela Branche,Pierre Damas,Maarten W. N. Nijsten,Dylan W. de Lange,Rodrigo Octavio Deliberato,Carolina F. Oliveira,Vera Maravic-Stojkovic,Alessia Verduri,Bianca Beghe,Bin Cao,Yahya Shehabi,Jens-Ulrik Stæhr Jensen,Caspar Corti,Jos A H van Oers,Albertus Beishuizen,Armand R. J. Girbes,Evelien de Jong,Matthias Briel,Matthias Briel,Matthias Briel,Beat Mueller +45 more
TL;DR: Widespread implementation of procalcitonin protocols in patients with acute respiratory infections has the potential to improve antibiotic management with positive effects on clinical outcomes and on the current threat of increasing antibiotic multiresistance.
Journal ArticleDOI
Biomarkers as point‐of‐care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care
Rune Aabenhus,Jens-Ulrik Stæhr Jensen,Karsten Juhl Jørgensen,Asbjørn Hróbjartsson,Lars Bjerrum +4 more
TL;DR: The high level of heterogeneity and the statistically significant test for subgroup differences between the three RCTs and three cluster-RCTs suggest that the results of the meta-analysis on antibiotic use should be interpreted with caution and the pooled effect estimate (risk ratio) may not be meaningful.
Journal ArticleDOI
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
Philipp Schuetz,Albertus Beishuizen,Michael Broyles,Ricard Ferrer,Gaëtan Gavazzi,Eric Gluck,Juan González del Castillo,Jens-Ulrik Stæhr Jensen,Jens-Ulrik Stæhr Jensen,Péter Kanizsai,Andrea L. Kwa,Stefan Krueger,Charles Edouard Luyt,Michael Oppert,Mario Plebani,Sergey A. Shlyapnikov,Giulio Toccafondi,Jennifer Townsend,Tobias Welte,Kordo Saeed,Kordo Saeed +20 more
TL;DR: A combination of clinical patient assessment with PCT levels in well-defined ABS algorithms, in context with continuous education and regular feedback to all ABS stakeholders, has the potential to improve the diagnostic and therapeutic management of patients suspected of bacterial infection, thereby improving ABS effectiveness.